Opportunities for Orphan Crops: Expected Economic Benefits From Biotechnology.
DREAMpy
GMO crops
economic surplus model
impact assessment
regulatory policy
sub-Sahara Africa
Journal
Frontiers in plant science
ISSN: 1664-462X
Titre abrégé: Front Plant Sci
Pays: Switzerland
ID NLM: 101568200
Informations de publication
Date de publication:
2022
2022
Historique:
received:
30
11
2021
accepted:
03
05
2022
entrez:
25
7
2022
pubmed:
26
7
2022
medline:
26
7
2022
Statut:
epublish
Résumé
An enabling, evidence-based decision-making framework is critical to support agricultural biotechnology innovation, and to ensure farmers' access to genetically modified (GM) crops, including orphan crop varieties. A key element, and often a challenge in the decision-making process, involves the balancing of identified potential risks with expected economic benefits from GM crops. The latter is particularly challenging in the case of orphan crops, for which solid economic data is scarce. To address this challenge, the International Food Policy Research Institute (IFPRI) in collaboration with local economists analyzed the expected economic benefits to farmers and consumers from the adoption of GM crops in 5 sub-Saharan African countries. This paper focuses on case studies involving insect-resistant cowpea in Nigeria and Ghana; disease-resistant cassava in Uganda and Tanzania; and disease-resistant banana in Uganda. Estimations from these case studies show substantial economic benefits to farmers and consumers from the timely adoption and planting in farmers' fields of GM orphan crops. Our analysis also shows how the benefits would significantly be reduced by regulatory or other delays that affect the timely release of these crops. These findings underscore the importance of having an enabling policy environment and regulatory system-covering, among other elements, biosafety and food/feed safety assessment, and varietal release registration-that is efficient, predictable, and transparent to ensure that the projected economic benefits are delivered and realized in a timely manner.
Identifiants
pubmed: 35873974
doi: 10.3389/fpls.2022.825930
pmc: PMC9297366
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
825930Informations de copyright
Copyright © 2022 Zambrano, Wood-Sichra, Ruhinduka, Phillip, Nin Pratt, Komen, Kikulwe, Falck Zepeda, Dzanku and Chambers.
Déclaration de conflit d'intérêts
JK was employed by Komen Bioscience Consultancy. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Res Eval. 2018;27(2):145-156
pubmed: 33487888
Front Plant Sci. 2021 Mar 22;12:605937
pubmed: 33828569
PLoS One. 2018 Aug 8;13(8):e0201803
pubmed: 30089159
GM Crops Food. 2014 Jan-Mar;5(1):44-57
pubmed: 24499745
Nat Biotechnol. 2018 Feb 6;36(2):137-139
pubmed: 29406500
Planta. 2019 Sep;250(3):677-694
pubmed: 31190115
PLoS One. 2017 Jul 27;12(7):e0181353
pubmed: 28749984